The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

Tryngolza (olezarsen) has been approved by the U.S. Food and Drug Administration as an adjunct to diet to reduce ...

Thousands of Americans are diagnosed every year with Parkinson’s Disease. It’s a movement disorder that affects the central ...

The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...

The U.S. Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said Sally Seymour, M.D., director of the Division of Pulmonology, Allergy, and Critical ...

The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.

20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ... The agency said that along with the drug, a reduced-calorie diet and increased physical activity should also be ...

The agency issued its decision on Friday, giving the stamp of approval for Zepbound's use among adults with obesity for use in combination with a reduced-calorie diet ... FDA's Center for Drug ...

The U.S. Food and Drug Administration has approved Ionis Pharmaceuticals' drug to treat a rare genetic disorder, making it ...

It should be used with a reduced-calorie diet and ... the new FDA green light doesn't expand the number of people who may be eligible for the drug, since the sleep apnea approval is specifically ...